Drug Trial Radar · NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
12,800
Planned (sponsor's estimate)
Start
Jul 25, 2025
Primary completion
Jun 30, 2028
Study completion Sep 29, 2030
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jun 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.
Conditions
- Atherosclerotic Cardiovascular Disease
- Overweight
- Obesity
Interventions
Maridebart CafraglutideDrug
Maridebart cafraglutide will be administered SC.
PlaceboDrug
Placebo will be administered SC.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, Myocardial Infarction (MI), or Ischemic Stroke (3-point Major Adverse Cardiac Events [3-P MACE])Time frame: Up to approximately 35 months
- Time to First Occurrence of a Composite Endpoint Consisting of: All-cause Death, MI, Ischemic Stroke, Coronary Revascularization, or Heart Failure (HF) Event (5-point MACE)Time frame: Up to approximately 35 months
Locations
783 sites in 36 countries. Site status is shown where the registry gives one.
Alliance For Multispecialty Research - Daphne
Daphne, Alabama
Eastern Shore Research Institute
Fairhope, Alabama
Huntsville Clinical Research, LLC
Huntsville, Alabama
Mobile Heart Specialists PC
Mobile, Alabama
Syed Research Consultants LLC
Sheffield, Alabama
Synexus Clinical Research US, Inc.
Phoenix, Arizona
Medical Advancement Centers of Arizona
Phoenix, Arizona
Valley Clinical Trials, LLC dba Flourish Research
Covina, California
Velocity Clinical Research- Huntington Park
Huntington Park, California
Velocity Clinical Research- Los Angeles
La Mesa, California
Orange County Research Center
Lake Forest, California
Biopharma Informatic - The Cardiovascular Center
Redding, California
Acclaim Clinical Research
San Diego, California
Encompass Clinical Research
Spring Valley, California
Diablo Clinical Research
Walnut Creek, California
Focus Clinical Research
West Hills, California
Family Practice Associates
Wilmington, Delaware
Excel Medical Clinical Trials
Boca Raton, Florida
Velocity Clinical Research - New Smyrna Beach
Edgewater, Florida
Alliance for Multispecialty Research - Fort Myers
Fort Myers, Florida
Elite Cardiac Research Center LLC
Hialeah, Florida
Elite Clinical Research
Hialeah, Florida
Zenith Clinical Research
Hollywood, Florida
Encore Medical Research LLC
Hollywood, Florida
East Coast Institute for Research, LLC
Jacksonville, Florida
Clinical Research of Central Florida
Lakeland, Florida
South Florida Clinical Research
Margate, Florida
Finlay Medical Research
Miami, Florida
Suncoast Research Group LLC
Miami, Florida
New Horizon Research Center
Miami, Florida
Panax Clinical Research
Miami Lakes, Florida
San Marcus Research Clinic Inc
Miami Lakes, Florida
Indago Research and Health Center
Miami Lakes, Florida
West Orange Endocrinology
Ocoee, Florida
Cardiology Partners Clinical Research Institute
Palm Beach Gardens, Florida
Peace River Cardiovascular Center
Port Charlotte, Florida
Progressive Medical Research
Port Orange, Florida
Saint Johns Center for Clinical Research
Saint Augustine, Florida
Intercoastal Medical Group
Sarasota, Florida
Winter Haven Hospital
Winter Haven, Florida
Showing 40 of 783 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.